Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sirtris Pharmaceuticals has obtained exclusive, worldwide rights from Robarts Research Institute for NamPRT, an important genetic driver of cellular stress resistance and longevity in mammals.
Subscribe to our email newsletter
In research relating to atherosclerosis and cellular aging, researchers showed that the introduction of the NamPRT gene into aging human vascular smooth muscle cells delayed their deterioration and substantially lengthened cell lifespan.
Karl Normington, senior director of intellectual property and licensing at Sirtris, said: “In-licensing the exclusive rights to these patents is part of our overall strategy to build the broadest platform of technology and intellectual property for the development of sirtuin therapeutics for the treatment of diseases of aging.”